Overview

Liquid Somatropin Formulation in Children With Growth Hormone Deficiency

Status:
Completed
Trial end date:
2004-03-22
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to evaluate the acceptance of the new liquid growth hormone formulation, somatropin, in children with growth hormone deficiency.
Phase:
Phase 4
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Hormones